期刊文献+

胰高血糖素样肽-1的胰腺外作用研究进展 被引量:1

下载PDF
导出
摘要 近年来,大量的研究表明胰高血糖素样肽-1( GLP-1)是一种有潜力的新型降糖药,不但能有效的调节血糖,改善胰岛β细胞功能,还具有多种胰腺外作用,如保护心血管系统、降低血压、调节脂代谢、改善氧化应激,减少炎症反应、调节骨代谢、减轻体质量、调节中枢神经系统、预防非酒精性脂肪肝、改善糖尿病肾病、改善多囊卵巢综合征等,具有广泛的临床应用价值。本文就GLP-1的胰腺外作用的最新研究进展作一综述。
作者 聂凤芹 刘雅
出处 《四川医学》 CAS 2016年第10期1184-1188,共5页 Sichuan Medical Journal
  • 相关文献

参考文献3

二级参考文献73

  • 1YangZ, MingXF. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 2006; 4: 53-65.
  • 2Bauer V, Sotnikova R. Nitric oxide -- the endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys 2010; 29: 319-40.
  • 3Stankevicius E, Kevelaitis E, Vainorius E, Simonsen U. Role of nitric oxide and other endothelium-derived factors. Medicina (Kaunas) 2003; 39: 333-41.
  • 4Drucker DJ. The biology of incretin hormones. Cell Metab 2006; 3: 153-65.
  • 5Drucker D J, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006; 368: 1696-705.
  • 6Meier J J, Nauck MA. Incretinsand the development of type 2 diabetes. Curr Diab Rep 2006; 6: 194-201.
  • 7Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, etal. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 2001; 86: 3717-23.
  • 8Briones M, Bajaj M. Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus. Expert Opin Pharmacother 2006; 7: 1055-64.
  • 9Golpon HA, Puechner A, Welte T, Wichert PV, Feddersen CO. Vaso- relaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat. Regul Pept 2001; 102: 81-6.
  • 10Nathanson D, Erdogdu O, Pernow J, Zhang Q, Nystrom T. Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo. Regul Pept 2009; 157: 8-13.

共引文献24

同被引文献15

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部